Chang et al. followed treatment-naïve CHB patients with normal ALT and HBV DNA < 2000 IU/mL for up to 3 years and demonstrated no correlation between hepatic steatosis and fibrosis progression [31]. This evidence concerns the gene GPT and fatty liver disease.